Building on the successful launch of the ELRIG Advances in Recombinant Protein Technology conference in 2013, we are pleased to announce the 2nd in this series of meetings. The 2016 conference will focus on the latest advances in technologies for the design and production of recombinant proteins used as biotherapeutics and as reagents in drug discovery.
Understanding how to facilitate expression of novel and difficult proteins through protein and cell line engineering will be essential to support future drug discovery. It is an absolute prerequisite for drug discovery that recombinant proteins can be produced in sufficient amounts and are of appropriate quality. The repertoire of novel biologics has expanded beyond classical antibodies into production of therapeutic proteins and complex antibody formats that pose fresh challenges for existing expression systems.
During this two day conference, researchers from top academic and industrial laboratories will discuss the latest advances in recombinant protein technology. Themes will address our current understanding of molecular events that determine quality and productivity and the use of specific cell hosts for particular types of protein product. In particular, the conference will focus on the biology of existing host cells (with respect to their competency for protein expression) and how both host cell and desired proteins may be engineered to generate new systems for enhanced product expression. Presentations will cover developments in the following crucial areas in meeting future demands for recombinant proteins in drug discovery:
*Host Cell Factories
*Genome Editing
*Protein Engineering, Novel Proteins and Peptide Scaffolds
The two day conference will consist of oral presentations by plenary speakers and speakers selected from offered abstracts. In addition there will be a poster session with significant opportunities for networking.
This is a must-attend event to learn about the latest trends in Recombinant Protein Technology and new state-of-the-art technologies in drug discovery!
Venue:
AstraZeneca
Location: PGN entrance Pepparedsleden 5, Mölndal
Country: Sweden
Organiser Contact Details:
ELRIG UKT:
01904 405177info@elrig.org
AstraZeneca
